Day: April 20, 2020

DENVER, April 20, 2020 (GLOBE NEWSWIRE) — DCP Midstream, LP (NYSE: DCP) will host a conference call to discuss its first quarter 2020 earnings at 11:00 a.m. ET on Thursday, May 7, 2020, which will be released after the New York Stock Exchange closes for trading on Wednesday, May 6, 2020.The live audio webcast of the conference call and accompanying presentation slides can be accessed through the Investors section on the DCP website at www.dcpmidstream.com and the conference call can be accessed by dialing (844) 233-0113 in the United States or (574) 990-1008 outside the United States. The conference confirmation number is 5152804.A replay of the conference call will be available until May 21, 2020, by dialing (855) 859-2056 in the United States or (404) 537-3406 outside the United States and using the above conference confirmation...

DALLAS, April 20, 2020 (GLOBE NEWSWIRE) — Triumph Bancorp, Inc. (Nasdaq: TBK) (“Triumph” or the “Company”) today announced earnings and operating results for the first quarter of 2020.As part of how we measure our results, we use certain non-GAAP financial measures to ascertain performance.  These non-GAAP financial measures are reconciled in the section labeled “Metrics and non-GAAP financial reconciliation” at the end of this press release.2020 First Quarter Highlights and Recent DevelopmentsFor the first quarter of 2020, net loss available to common stockholders was $4.5 million. Diluted losses per share were $0.18. On January 1, 2020, we adopted Accounting Standard Update 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” commonly referred to as the Current Expected...

SOUTH SAN FRANCISCO, Calif., April 20, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that it will report first quarter 2020 financial results on Thursday, May 7, 2020, after the close of the market.Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will host a conference call and webcast at 2:30 p.m. PT / 5:30 p.m. ET on May 7, 2020, to discuss first quarter 2020 financial results and operational progress. A press release outlining the financial results will be publicly distributed before the call.Individuals interested in listening to the conference call may do so by dialing:US domestic callers: (877) 556-5248Outside US callers: (720) 545-0029Please reference Conference...

SAN CLEMENTE, Calif., April 20, 2020 (GLOBE NEWSWIRE) — CareTrust REIT, Inc. (Nasdaq:CTRE) today announced that its annual meeting of stockholders (the “Annual Meeting”) scheduled to be held at 9:00 a.m. PDT on Thursday, April 30, 2020 at CareTrust’s offices located at 905 Calle Amanecer, Suite 300, San Clemente, California 92673, will be opened to allow for virtual attendance via teleconference. This option to attend by telephone reflects CareTrust’s concern for the health and well-being of its stockholders, board and management during the current COVID-19 pandemic while still providing an opportunity for them to participate in the Annual Meeting.To participate in the Annual Meeting, stockholders must email their full name, address and (if the stockholder’s shares are not held in their own name) a copy of the legal proxy obtained...

BEIJING, China and CAMBRIDGE, Mass., April 20, 2020 (GLOBE NEWSWIRE) — BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted a supplemental new drug application (sNDA) of BeiGene’s anti-PD-1 antibody tislelizumab in combination with two chemotherapy regimens for first-line treatment of patients with advanced squamous non-small cell lung cancer (NSCLC).“This sNDA filing is another important milestone in tislelizumab’s development program, coming on the heels of its recent approval in urothelial carcinoma in China – our first approval in solid tumors...

NEW YORK, April 20, 2020 (GLOBE NEWSWIRE) — The Nasdaq Stock Market announced today that it will delist the common stock of Internap Corporation. Internap Corporation’s common stock was suspended on March 26, 2020 and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the American Depository Shares of Paringa Resources Limited. Paringa Resources Limited’s American Depository Shares were suspended on March 5, 2020 and have not traded on Nasdaq since that time.Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting. The delisting becomes effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delisting and whether the companies’ securities are trading on another venue, please...

JACKSONVILLE, Fla., April 20, 2020 (GLOBE NEWSWIRE) — Stein Mart, Inc. (NASDAQ: SMRT) today announced that it qualifies for recently announced temporary relief from compliance with The Nasdaq Stock Market (Nasdaq) $1.00 minimum bid price requirement (the “Minimum Bid Price Requirement”).As previously disclosed, Nasdaq had advised the company that it had until July 6, 2020 to regain compliance with the Minimum Bid Price Requirement. However, on April 16, 2020, Nasdaq announced that, in response to the COVID-19 pandemic and related extraordinary market conditions, it is providing temporary relief from bid price and other requirements through June 30, 2020. As a result, the Company has until September 18, 2020 to regain compliance with the Minimum Bid Price Requirement.Stein Mart is evaluating its options to regain compliance...

SOUTH SAN FRANCISCO, Calif., April 20, 2020 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced the closing of its previously announced public offering of 5,750,000 shares of common stock, including 750,000 shares sold pursuant to the underwriter’s exercise in full of its option to purchase additional shares. Gross proceeds from the offering at a public offering price of $6.25 per share, before underwriting discounts and commissions and offering expenses, were approximately $36 million.Citigroup acted as the sole book-running manager for the offering.A shelf registration statement relating to the offered shares of common stock was filed...

SCHAUMBURG, Ill., April 20, 2020 (GLOBE NEWSWIRE) — Paylocity Holding Corporation (Nasdaq: PCTY), a leading provider of cloud-based HR and payroll software solutions, today announced that it has scheduled a conference call to review its third quarter fiscal 2020 results for Thursday, May 7th at 4:00 pm Central Time (5:00 pm Eastern Time).To listen to the conference call live, dial (855) 226-3021 or (315) 625-6892. The conference ID is 8645298. Please dial in at least five minutes before the scheduled start time. A live webcast can be accessed at www.paylocity.com.A replay of the call will be available and archived via webcast at www.paylocity.com.About Paylocity Paylocity is a leading provider of cloud-based HR and payroll software solutions headquartered in Schaumburg, IL. Founded in 1997 and publicly traded since 2014, Paylocity...